Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 82-1199380 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To lead the development and ongoing management of clinical trial platforms to accelerate the discovery and development of treatments for patients with rare and deadly diseases.
Principal Officer
Meredith Buxton
Total Revenue
$27.7M
FY2024
Total Expenses
$30.9M
FY2024
Net Assets
$39.2M
Program Ratio
86.8%
expenses on programs
Employees
39
Volunteers
5
Board Members
8
Voting
5
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.